chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Rash, mostly on torso but some on face and extremities  First noticed rash when she woke from a nap, around 4:45pm on the day of vaccination.  Called Peds office and they advised to take her to urgent care.  When to Urgent Care and was seen around 7pm.  Doctor noted rash seemed similar to rashes seen in children with viral infections.  He was not concerned about the rash.  Did not feel it indicated an allergic reaction.  She had no other issues or symptoms.  No fever.  No difficulty breathing.  Lungs sounded good according to doctor.  Rash did not seem to be itchy or otherwise bother her.  Other than the rash, she was perfectly fine.  Rash is still slightly present two days after vaccination as tiny raised bumps on her torso.
This is a 38 year old who received a non-primary smallpox vaccination 01/12/2004. He states that he had body aches and did not feel good in general for about 3 weeks, but resolved without development of other problems. He states that he had minimal response to his smallpox vaccine. He was deployed on 02/12/2004.  On 29 February 2004 he began to experience severe stomach cramps, diarrhea and nausea. He was seen in medical and told that he had a viral gastroenteritis that was going around. He also experienced night sweats, but does not feel that he had a fever.  On 03 Mar 2004 upon waking was experiencing substernal chest pain (5/10), shortness of breath and numbness in his left arm. He tried to stretch it out, but after 30 minutes had no success. He went to the medical tent he was placed on oxygen, intravenous fluids and aspirin. The physician did not think he had a heart attack because he could walk ~ 100 yards without difficulty. He was however, transferred via ambulance to the Emergency Department.   At the emergency department, he was given sublingual nitroglycerin which helped the pain (0-1/10). His shortness of breath also improved. Labs and electrocardiogram were obtained. It revealed He was then admitted to the Coronary Care Unit for further evaluation and treatment. He was placed on IV nitroglycerin drip. He remained in until approximately 1600 hours that day.  He was then transferred to another hospital after experiencing a second "attack" at about 1300 hours.   At the hospital, they continued medication regimine, completed an echocardiogram. He remained at Landstahl until 03/06/04 when he was transferred to another hospital.  He continued supportive care. On 03/07/04 he had a repeat echocardiogram. He was scheduled for a coronary angiography, but it was postponed until 03/10/04. The study showed all of his major coronary arteries to be clean. He was discharged on 03/11/04 and placed in medical hold until 03/15/04 after re-evaluation with cardiology. He's final diagnosis was myopericarditis in temporal association with smallpox vaccination and viral illness.  Nurse follow up on 05/27/04 states: "Complete."
On 3/13 my mother reported just feeling right.  Only lasted a short time.  On 3/14 she had  mild stroke like symptoms.  Went to ER.  Symptoms improved. Diagnosis- dehydration. Discharged home fully alert and oriented. 3/15 Back to ER for altered level of consciousness in Early afternoon.  Her level of consciousness continued to deteriorate until she became totally confused and eventually unresponsive for 3 days. (I have video if needed, I will also provide and tested results you request).  They r/o a stroke, UTI, pneumonia and dehydration.  Diagnosis on admission was encephalopathy.   Six months later she is still have issues with slow thought processing, extreme fatigue, weakness and episodes of  confusion.   She was totally independent prior to this reaction.  Now she is not.
Redness and swelling on left arm started 1-13-15. 1-14-15 swelling had increased to 4-5" square and was itchy. Seen by private physician who felt a Vaers report needed to be completed. Advised to give Benadryl and apply ice to the area.
Eyes didn't focus; headache; Extreme fatigue/ very tired/She stays in bed all the time; Achy; Extremely cold; burning up; Sweating; cold sweats; Short of breath; vertigo; This spontaneous case was reported by a consumer and describes the occurrence of VISION BLURRED (Eyes didn't focus), VERTIGO (vertigo), FEELING COLD (Extremely cold), BURNING SENSATION (burning up) and HYPERHIDROSIS (Sweating) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 049C21A and 027C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Lyme's disease and Fibromyalgia. Concurrent medical conditions included Blood pressure high. Concomitant products included CLONAZEPAM, LISINOPRIL and PAROXETINE for an unknown indication.   On 14-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Jun-2021, the patient experienced FEELING COLD (Extremely cold), BURNING SENSATION (burning up), HYPERHIDROSIS (Sweating), COLD SWEAT (cold sweats), HEADACHE (headache), FATIGUE (Extreme fatigue/ very tired/She stays in bed all the time) and MYALGIA (Achy). In June 2021, the patient experienced VERTIGO (vertigo) and DYSPNOEA (Short of breath). On an unknown date, the patient experienced VISION BLURRED (Eyes didn't focus). The patient was treated with CYANOCOBALAMIN (VITAMIN B 12 [CYANOCOBALAMIN]) at a dose of 1 dosage form twice a day and VITAMINS NOS at an unspecified dose and frequency. On 21-Jun-2021, FEELING COLD (Extremely cold) and MYALGIA (Achy) had resolved. At the time of the report, VISION BLURRED (Eyes didn't focus) and VERTIGO (vertigo) outcome was unknown, BURNING SENSATION (burning up), HYPERHIDROSIS (Sweating) and COLD SWEAT (cold sweats) was resolving and DYSPNOEA (Short of breath), HEADACHE (headache) and FATIGUE (Extreme fatigue/ very tired/She stays in bed all the time) had not resolved.     The treatment information was patient doctor advised that take fruits and veggies and vitamins in her diet to remove the bad food   This case was linked to MOD-2021-251824 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 06-Aug-2021: Follow up received and Additional  event (illness) was added.
lymphadenopathy - pain in right side of neck , small squishy lump at top of collarbone. Nothing to do other than keep an eye on symptoms and follow up with DR as needed.
Days following injection: swollen lymph node under left arm, fever, body aches, headache, fatigue,  November -January headaches off and on, not able to predict occurrences. January - head aches get worse start to notice that I get angry before they show up, they come with light sensitivity and a persistence and tylenol, advil nor caffeine seem to do anything to help. Feb 26, 6:am tried to go to work. Saw boss  at about 8:00am ,went up the chair to get to work,9:00 am could remember how to put barrette into my hair, called husband, called boss, came back down to lower elevation. Called Urgent care at about 10 am describing facial pain around my right eye and pain in my right eye an piercing pain like a needle through my right side of my brain. Co-worker took me to the ER. they put me on oxygen. head ache started to dissipate and BP came down. Heart rate was mid 40's to mid 50's. On call doctor made an appointment for me with the neurologist Dr.
Moderna COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Received Moderna Vaccines on 1/12/2021, 2/11/2021, and 8/24/2021. Admitted 2/3/22 for acute hypoxic resp failure 2/2 Covid 19 w/superimposed bacterial PNA c/b sepsis, NSTEMI, and sepsis. Intubated 2/4/22. Tx'd w/antibiotics, pressors, steroids, and remdesivir. Respiratory status continued to decompensate. Extubated to comfort measures and expired 2/20/2022 at 0920.
There was no adverse reaction. The purpose of this report is to report that patient's booster dose was administered 3 days earlier than recommended.
immed p/inject both legs became hot & completely covered in an urticarial rash; given DPH;
Sudden HHE. Went totally pale, unresponsive, wouldn't nurse, wouldn't open eyes, no response to shouting name or tapping cheek, appeared dead, breathing shallowly. Called 911 immediately. EMTs arrived. Attempted to rouse him. Color returned to face, but eyes still closed and not responding to touch or pain when heel pricked to test glucose levels.  Taken to ER. After being undressed and hooked up to EKG, O2, and blood pressure cuff, opened eyes, fussed, and became alert. Nursed well within 30 minutes. Returned to normal self after a couple hours. Discharged from ER at 7:20 pm.
Rash & pain at injection site (~ 3" inch diameter), oval shape rash /redness.
This spontaneous report was received from a physician refers to a patient of unknown age and gender. No information was provided regarding the patient's medical history, concurrent conditions or concomitant medications. On 23-JAN-2018, the patient was vaccinated with a dose of improperly stored GARDASIL 9 lot number N017697, expiration date 21-JAN-2020 for prophylaxis (frequency and route of administration were not reported). On unknown dates, the dose of GARDASIL 9 underwent temperature excursions of below 32 degrees Fahrenheit (°F) for 9 hours 6 minutes and 32 °F up to 35 °F 19 hours 11 minutes, which were detected by the data logger. No previous temperature excursions were reported. No adverse effects were reported. This is one of several cases received from the same reporter. Sender's Comments: US-009507513-1801USA010690: US-009507513-1802USA004842: US-009507513-1801USA010882.
Myalgia, fever, chills, headache from 2000 hrs on 12/29/2020 lasting until 0600 hrs 12/30/2020
pain in arm 12AUG98;on 5SEp98 went back to hosp;MD did not see any infect or swelling;told to take APAP;pain got worse;It spread to other arm, legs & to muscles throughout body;had diff using arms,walking;pain keeps pt awake at night  Annual follow-up received on 9/27/00 states that the pt experienced constant severe pain lasting approximately 10 months until which she was diagnosed with fibromyalgia believed to be caused by the tetanus vaccine.
A  large red, warm, slightly itchy rash appeared around the vaccination site one week after my vaccination.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. No information was provided regarding concomitant medications, concurrent conditions or medical history. In 2015, the patient was inoculated with the ZOSTAVAX vaccine as recommended for routine adult health maintenance for the prevention of shingles (dose, route, and lot number not provided). The vaccine did not prevent shingles as intended and the patient subsequently contracted a persistent strain of herpes zoster or shingles. In 2016, the patient was treated at a hospital for a severe vesicular outbreak and decreased immune symptoms which was diagnosed as herpes zoster or shingles. As a direct and proximate result of ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown. Causality assessment was related. Additional information has been requested.
Flublok was written in patients chart when Fluzone was actaully given to the patient
States he received his flu shot and approximately an hour later he began to feel a "stiffness" in his neck on the right side. He is able to complete flexion/extension and lateral flexion but with "soreness." He denies muscle weakness, tenderness or tingling in his extremities at this time and is afebrile and in no acute distress. Ambulating without difficulty.
Patient received a Fluad vaccine on 9/28/22 and then she received a Fluad on 11/28/22.
Person was given 0.3cc dose of Janssen Booster dose instead of standard 0.5 cc. notified and Manufacturer (Janssen) notified and all persons reported to Janssen Manufacturer for their Pharmacy department, recommendations from the Manufacturer and with agreement are to notify all of the recipients that received an incorrect dose and submit a VAERS report for each.
This spontaneous report as received from a nurse refers to a 13 year old patient of unknown gender. The patient's relevant medical history, concurrent conditions, concomitant medications, drug reactions or allergies were not reported. On 05-SEP-2017, the patient was vaccinated with improperly stored GARDASIL 9 (dosing details were not reported) (lot # N007931, expiry date: 17-NOV-2019) for prophylaxis. No adverse effects were reported. Temperature excursion was from 0 degree Celsius (C) to 1 degree C (0.8 degree C) for 52 minutes. The previous temperature excursion was reported as from 9 degree C to 25 degree C (10.9 degree C) for 3 hours 17 minutes. The call was because of a data logger. No product quality complaint involved. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1709USA000054.
Sore arm, body ache RASH :  light colored over entire body for 24 hours, not itchy , no pai.
NEAR SYNCOPE, HYPOTENSION AND BRADYCARDIA. CHILD WAS HYPERVENTILATING. BP DROPPED TO 79/43 WITH PULSE 44. PULSE OX 100%. TREATED WITH REST, MONITORING. PAPER BAG REBREATHING. GIVEN ORANGE AND WATER. GRADUALLY RECOVERED, NORMAL VS AT D/C, OBSERVED FOR 25 MINUTES. PLEASE NOTE THAT SIBLING ALSO HAD SYNCOPE.
Arm and back -neck-painful-nausea-headache-fatigue-stayed in bed for two days-took a full week and a half to recover.
her period started a week earlier; her period was heavier than usual; tingling in arm and hand while driving; Had a head to toe rash/head to toe rash with welts; This spontaneous case was reported by an other health care professional and describes the occurrence of MENSTRUAL DISORDER (her period started a week earlier), HEAVY MENSTRUAL BLEEDING (her period was heavier than usual), PARAESTHESIA (tingling in arm and hand while driving) and RASH (Had a head to toe rash/head to toe rash with welts) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 059E21A) for COVID-19 vaccination.     Concurrent medical conditions included Erythromelalgia. Concomitant products included DULOXETINE HYDROCHLORIDE (CYMBALTA), ACETYLSALICYLIC ACID (ASPIRIN ACTIV), AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL), MOMETASONE FUROATE (ASMANEX HFA) and LEVOSALBUTAMOL TARTRATE (XOPENEX HFA) for an unknown indication.    On 31-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Aug-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced RASH (Had a head to toe rash/head to toe rash with welts). On an unknown date, the patient experienced MENSTRUAL DISORDER (her period started a week earlier), HEAVY MENSTRUAL BLEEDING (her period was heavier than usual) and PARAESTHESIA (tingling in arm and hand while driving). At the time of the report, MENSTRUAL DISORDER (her period started a week earlier), HEAVY MENSTRUAL BLEEDING (her period was heavier than usual), PARAESTHESIA (tingling in arm and hand while driving) and RASH (Had a head to toe rash/head to toe rash with welts) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient also took concomitant medications of Cranberry Pill and Antiarin. No treatment medications are provided by reporter.   Most recent FOLLOW-UP information incorporated above includes: On 30-Aug-2021: Follow Up received on 30-AUg-2021 contains additional primary reporter and mentioned additional AE contact.
About  10 days after vaccine, pressure in right ear, ear closed up and I couldn't hear. Went to Urgent Care. They put a wick in it and gave me Antibiotics with Ofloxacin ear drops. Following evening, other ear closed, with pain. My brother was yelling and I couldn't hear what he was saying. Went to ER, New script Zipro, took wick out, gave me a shot for the pain. Full recovery took 2 weeks.
stopped medication for 1 week, 2 weeks ago while he got his COVID vaccine. Has since resumed; This is a spontaneous report received from contactable reporter(s) (Other HCP) for a sponsored program (051529).  A 53 year-old male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: XELJANZ XR, start date: 01Mar2021. The following information was reported: THERAPEUTIC RESPONSE UNEXPECTED (non-serious), outcome "unknown", described as "stopped medication for 1 week, 2 weeks ago while he got his COVID vaccine. Has since resumed".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
A patient was administered a booster dose twice on the same day; This spontaneous case was reported by a pharmacist and describes the occurrence of EXTRA DOSE ADMINISTERED (A patient was administered a booster dose twice on the same day) in a 41-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013F21A, 013F21A, 004M20A and 040A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form and third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 15-Nov-2021, the patient experienced EXTRA DOSE ADMINISTERED (A patient was administered a booster dose twice on the same day). On 15-Nov-2021, EXTRA DOSE ADMINISTERED (A patient was administered a booster dose twice on the same day) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided. No treatment medications were reported. The patient was observed for 30 minutes and showed no symptoms.
contracted COVID-19 3 days after being vaccinated/developed pneumonia due to the COVID-19 infection; This is a spontaneous report from a contactable consumer (patient's sister). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as a single dose for COVID -19 immunization. Medical history included rheumatoid arthritis. The patient's concomitant medications were not reported. The patient contracted COVID-19 3 days after being vaccinated, she has preexisting medical conditions (including rheumatoid arthritis) and is still in the hospital. She developed pneumonia due to the COVID-19 infection. Outcome of the event was unknown.  Information on the lot/batch number has been requested.
Expired vaccine used; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Nov-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 24-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) to be not related.    No concomitant medication was provided. The patient's allergic information was unknown. The event did no caused the patient to seek medical care. There were no any other potential causes. No adverse reaction was reported. No treatment information was provided.
pain at injection site; This case was reported by a other health professional via sales rep and described the occurrence of injection site pain in a female patient who received Men B NVS (Bexsero) for prophylaxis.   On an unknown date, the patient received Bexsero at an unknown dose. On an unknown date, immediately after receiving Bexsero, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was unknown.   It was unknown if the reporter considered the injection site pain to be related to Bexsero.  Additional case details were reported as follows: The age at vaccination was not reported. The reporter reported that when the patient was given the vaccine she said that Bexsero "hurts". She explained further and said was referring to injection site pain. Consent to follow up was denied.
This spontaneous report as received from a nurse practitioner refers to her 18 month old granddaughter. On approximately 13-FEB-2014, about 6 weeks ago, the patient was vaccinated with a dose of unspecified varicella containing vaccine (manufacturer unknown) and another unspecified vaccine (manufacturer unknown). In February 2014, the patient developed a local injection site eruption of small vesicles on an unspecified date within 4 days of being vaccinated. In February 2014, shortly thereafter, the patient developed a similar outbreak spot on her stomach around the umbilicus and the outbreak had since spread around the patient's entire right side near her diaper band. The nurse practitioner stated that the vesicular rash was extremely itchy. The patient was taken to see an unspecified pediatrician on an unspecified date who prescribed the patient with unspecified oral steroids (manufacturer unknown), an unspecified antihistamine (manufacturer unknown) and an topical cream. The outcome of the events were not reported. Additional information has been requested.
On 11/12/99 the pt received his first IM-left deltoid dose of Lymerix for prevention of Lyme disease. (The pt is a hunter.)  Two days later, on 11/14/99, the pt experienced arthralgia and urticaria on arms, legs and trunk consisting of 4-5 spots.  The most recent information received on 12/7/99 reports the condition of the pt is ongoing, and the pt is getting worse.
Pt recvd 1st dose Hep B vax 3FEB92 & exp soreness @ inject site which resolved w/in 24 hrs; approx 6 days following vax pt devel migrane h/a w/photosensitivity, blindness in rt eye, poss dx of encephalitis; pt recvd 3wks prior to vax;
A nurse reported that on 13-NOV-2002, A 46-year-old female received injections of Flu-Shield (2002-2003 Formula), and PneumoVax 23 (MSD) vaccines.  On 14-NOV-2002, she developed a fever of 103 deg. F.  She recovered.  this is 1 of 3 patients from this facility who experienced fever following receipt of Flu-Shield (2002-2003 Formula) lot 4020024.
my arm just a little sore; This is a spontaneous report from a contactable consumer (patient). This 35-year-old non-pregnant female consumer received the first single dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EK8732) on 31Mar2021 at 07:00, in right arm, for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient did not have COVID. After the first vaccination the patient was ok, her arm was just a little sore on an unspecified date in 2021. Event outcome was unknown.  No follow-up attempts are needed. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021492259 same patient, vaccine, different dose and event